These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21447972)

  • 1. Stage I testicular non seminoma.
    Horwich A
    Onkologie; 2011; 34(4):162-3. PubMed ID: 21447972
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Nicola Nicolai, Rosalba Miceli, Andrea Necchi, et al. Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence. Eur Urol 2010;58:912-8.
    Akyol I; Soydan H; Ates F
    Eur Urol; 2011 Apr; 59(4):e20; author reply e21-2. PubMed ID: 21255907
    [No Abstract]   [Full Text] [Related]  

  • 3. Surveillance in patients with stage I nonseminomatous testicular tumors.
    Litwin MS; Richie JP
    Surg Annu; 1994; 26():89-99. PubMed ID: 8303525
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance results of patients with stage I nonseminomatous germ cell testicular cancer.
    Keskin S; Ekenel M; Başaran M; Bavbek S
    Onkologie; 2011; 34(4):173-6. PubMed ID: 21447974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
    Graham SD
    Semin Urol; 1993 May; 11(2):85-91. PubMed ID: 8395700
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current knowledge of risk factors for testicular germ cell tumors.
    Fukawa T; Kanayama HO
    Int J Urol; 2018 Apr; 25(4):337-344. PubMed ID: 29345008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Testicular tumors].
    Legrand G; Ploussard G; Mongiat-Artus P; Desgrandchamps F; Culine S
    Rev Prat; 2014 Apr; 64(4):557-60. PubMed ID: 24855796
    [No Abstract]   [Full Text] [Related]  

  • 10. Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy.
    Peckham MJ
    Prog Clin Biol Res; 1985; 203():523-38. PubMed ID: 2421341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of clinical stage I testicular germ cell tumours].
    Loriot Y; Fizazi K
    Bull Cancer; 2007 May; 94(5):439-48. PubMed ID: 17535781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular germ cell tumours in Iceland: a nationwide clinicopathological study.
    Agnarsson BA; Gudbjartsson T; Einarsson GV; Magnusson K; Thoroddsen A; Bergthorsson JT; Amundadottir L; Barkardottir RB; Björnsson J
    APMIS; 2006 Nov; 114(11):779-83. PubMed ID: 17078858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence.
    Nicolai N; Miceli R; Necchi A; Biasoni D; Catanzaro M; Milani A; Piva L; Pizzocaro G; Stagni S; Torelli T; Salvioni R
    Eur Urol; 2010 Dec; 58(6):912-8. PubMed ID: 20817343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local recurrence of malignant testicular tumors].
    Sortland V; Solheim 0P
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):18-9. PubMed ID: 163040
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic and therapeutic significance of retroperitoneal lymph node dissection in low stage and localized disease: point of view.
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():263-8. PubMed ID: 3008179
    [No Abstract]   [Full Text] [Related]  

  • 17. Spermatocytic seminoma with rhabdomyosarcomatous differentiation: a case report with a review of the literature.
    Menon S; Karpate A; Desai S
    J Cancer Res Ther; 2009; 5(3):213-5. PubMed ID: 19841567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
    Lieskovsky G; Weinberg AC; Skinner DG
    Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-seminoma testicular tumors; results of a treatment method focusing on retroperitoneal lymph node dissection].
    Schraffordt Koops H; Eibergen R; Oldhoff J; Van der Ploegen E; Vermey A
    Ned Tijdschr Geneeskd; 1978 Jul; 122(28):1020-6. PubMed ID: 209355
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of postchemotherapy surgery in managing metastatic germ cell tumors.
    Beck SD
    Cancer; 2007 Dec; 110(12):2601-3, i. PubMed ID: 17948907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.